Microdialysis as a Monitoring System for Human Diabetes

Applications of Microdialysis in Pharmaceutical Science

Volumn , Issue , 2011, Pages 359-401

  Ciechanowska, Anna ^a   Wojcicki, Jan M ^a   Maruniak Chudek, Iwona ^b   Ladyzynski, Piotr ^a   Krzymien, Janusz ^c  

^a INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Insulin and glucose uptake analysis by microdialysis technique, understanding physiological processes; MD application, in diabetes and diabetic complications glucose monitoring, in tissues and organs; Microdialysis (MD), as a monitoring system for human diabetes, and insulin sensitivity

Indexed keywords

EID: 84886167901     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118011294.ch12     Document Type: Chapter

References (186)

1. Pfeiffer, E.F. 1995. Germany: The Sugar Watch. Biosensors & Bioelectronics,3, vi-vii (1).
2. Schoemaker, M., Andreis, E., Röper, J., Kotulla, R., Lodwig, V., Obermaier, K., Stephan, P., Reuschling, W., Rutschmann, M., Schwaninger, R., et al. 2003. The SCGM1 system: subcutaneous continuous glucose monitoring based on microdialysis technique. Diabetes Technology & Therapeutics, 5 4, 599-608.
3. Maran, A., Poscia, A. 2002. Continuous subcutaneous glucose monitoring: the GlucoDay system. Diabetes, Nutrition & Metabolism, 15, 429-43.
4. Jeckelmann, J., Seibold, A. 2002. GlucOnlineTM: a new approach to continuous glucose monitoring. Diabetesprofi le, 2/02.
5. Kitabchi, A.E., Umpierrez, G.E., Murphy, M.B., Barrett, E.J., Kreisberg, R.A., Malone, J.I., Wall, B.M. 2001. Management of hyperglycemic crises in patients with diabetes. Diabetes Care, 24, 131-153.
6. Fishbein, H.A., Palumbo, P.J. 1995. Acute metabolic complications in diabetes. In: Diabetes in America, NIH Publ. 95-1468. National Diabetes Data Group, National Institutes of Health, Bethesda, MD, pp. 283-291.
7. Umpierrez, G.E., Kelly, J.P., Navarrete, J.E., Casals, M.M.C., Kitabchi, A.E. 1997. Hyperglycemic crises in urban blacks. Archives of Internal Medicine, 157,669-675.
8. Kitabchi, A.E., Fisher, J.N., Murphy, M.B., Rumbak, M.J. 1994. Diabetic ketoacidosis and the hyperglycemic hyperosmolar nonketotic state. In: Kahn, C.R., Weir, G.C. (Eds.), Joslin's Diabetes Mellitus. 13th ed., Lea & Febiger, Philadelphia, pp. 738-770.
9. Wachtel, T.J., Tetu-Mouradjain, L.M., Goldman, D.L., Ellis, S.E., O'Sullivan, P.S. 1991. Hyperosmolality and acidosis in diabetes mellitus: a three-year experience in Rhode Island. Journal of General Internal Medicine, 6, 495-502.
10. Carroll, P., Matz, R. 1983. Uncontrolled diabetes mellitus in adults: experience in treating diabetic ketoacidosis and hyperosmolar coma with low-dose insulin and uniform treatment regimen. Diabetes Care, 6, 579-585.
11. Hamblin, P.S., Topliss, D.J., Chosich, N., Lording, D.W., Stockigt, J.R. 1989. Deaths associated with diabetic ketoacidosis and hyperosmolar coma, 1973-1988. Medical Journal of Australia, 151, 439-444.
12. Basu, A., Close, C.F., Jenkins, D., Krentz, A.J., Nattrass, M., Wright, A.D. 1992. Persisting mortality in diabetic ketoacidosis. Diabetic Medicine, 10,282-289.
13. Ellemann, K., Soerensen, J.N., Pedersen, L., Edsberg, B., Andersen, O. 1984. Epidemiology and treatment of diabetic ketoacidosis in a community population. Diabetes Care, 7, 528-532.
14. Chiasson, J.L., Aris-Jilwan, N., Bélanger, R., Bertrand, S., Beauregard, H.,ékoé, J.M., Fournier, H., Havrankova, J. 2003. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Canadian Medical Association Journal, 7, 168.
15. Krentz, A., Nattrass, M. 2003. Acute metabolic complications of diabetes: diabetic ketoacidosis, hyperosmolar non-ketotic hyperglycaemia and lactic acidosis. In: Pickup, J.C., Williams, G. (Eds.), Textbook of Diabetes 1, 3rd ed. Blackwell, Oxford, U.K.
16. English, P., Williams, G. 2004. Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Nigerian Postgraduate Medical Journal, 80, 253-261.
17. Ciechanowska, A., Ladyzynski, P., Wojcicki, J.M., Sabalinska, S., Krzymien, J., Pulawska, E., Karnafel, W., Foltynski, P., Kawiak, J. 2008. Microdialysis technique as a monitoring system for acute complications of diabetes. Artifi cial Organs, 32 1, 45-51.
18. Schoonen, A.J., Wientjes, K.J. 2003. A model for transport of glucose in adipose tissue to a microdialysis probe. Diabetes Technology & Therapeutics, 5 4,589-598.
19. Hagström-Toft, E., Enoksson, S., Moberg, E., Bolinder, J., Arner, P. 1997. Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. American Journal of Physiology: Cell Physiology, 273,584-592.
20. Coppack, S.W., Chinkes, D.L., Miles, J.M., Patterson, B.W., Klein, S. 2005. A multicompartmental model of in vivo adipose tissue glycerol kinetics and capillary permeability in lean and obese humans. Diabetes, 54 7, 1934-1941.
21. Kamel, A., Norgren, S., Persson B., Marcus, C. 1999. Insulin induced hypoglycaemia: comparison of glucose and glycerol concentrations in plasma and microdialysate from subcutaneous adipose tissue. Archives of Disease in Childhood, 42-45.
22. Bolinder, J., Ungerstedt, U., Arner, P. 1992. Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patients. Diabetologia, 35 12, 1177-1180.
23. Sternberg, F., Meyerhoff, C., Mennel, F.J., Bischof, F., Pfeiffer, E.F. 1995. Subcutaneous glucose concentration in humans: real estimation and continuous monitoring. Diabetes Care, 18 9, 1266-1269.
24. Wientjes, K.J., Vonk, P., Vonk-van Klei, Y., Schoonen, A.J., Kossen, N.W. 1998. Microdialysis of glucose in subcutaneous adipose tissue up to 3 weeks in healthy volunteers. Diabetes Care, 21 9, 1481-1488.
25. Monsod, T.P., Flanagan, D.E., Rife, F., Saenz, R., Caprio, S., Sherwin, R.S., Tamborlane, W.V. 2002. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care, 25, 889-893.
26. Stahl, M., Bouw, R., Jackson, A., Pay, V. 2002. Human microdialysis. Current Pharmaceutical Biotechnology, 3, 165-178.
27. Lutgers, H.L., Hullegie, L.M., Hoogenberg, K., Sluiter, W.J., Dullaart, R.P., Wientjes, K.J., Schoonen, A.J. 2000. Microdialysis measurement of glucose in subcutaneous adipose tissue up to three weeks in type 1 diabetic patients. Netherlands Journal of Medicine, 57 1, 7-12.
28. Rosdahl, H., Hamrin, K., Ungerstedt, U., Henriksson, J. 1998. Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion fl ow. American Journal of Physiology: Endocrinology and Metabolism,5, E936-E945.
29. Workgroup on Hypoglycemia, American Diabetes Association 2005. Defi ning and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care, 28, 1245-1249.
30. Cryer, P.E., Davis, S.N., Shamoon, H. 2003. Hypoglycemia in diabetes. Diabetes Care, 26, 1902-1912.
31. Cryer, P.E. 2004. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. New England Journal of Medicine, 350, 2272-2279.
32. Dagogo-Jack, S.E., Craft, S., Cryer, P.E. 1993. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus: recent antecedent hypogly-cemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. Journal of Clinical Investigation, 91, 819-828.
33. Segel, S.A., Paramore, D.S., Cryer, P.E. 2002. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes, 51, 724-733.
34. Tanenberg, R., Bode, B., Lane, W., Levetan, C., Mestman, J., Harmel, A.P., Tobian, J., Gross, T., Mastrototaro, J. 2004. Use of the continuous glucose monitoring system to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clinic Proceedings, 79, 1521-1526.
35. Daneman, D. 2006. Type 1 diabetes. Lancet, 367, 847-858.
36. The Diabetes Control and Complications Trial Research Group 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977-986.
37. The Diabetes Control and Complications Trial Research Group 1997. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes, 46,271-286.
38. Clarke, W.L., Cox, D.J., Gonder-Frederick, L.A., Julian, D., Schlundt, D., Polonsky, W. 1995. Reduced awareness of hypoglycemia in adults with IDDM. Diabetes Care, 18, 517-522.
39. Mastrototaro, J. 1999. The MiniMed Continuous Glucose Monitoring System (CGMS). Journal of Pediatric Endocrinology & Metabolism, 12 3, 751-758.
40. Veneman, T., Mitrakou, A., Mokan, M., Cryer, P., Gerich, J. 1993. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes, 1233-1237.
41. Fanelli, C.G., Paramore, D.S., Hershey, T., Terkamp, C., Ovalle, F., Craft, S., Cryer, P.E. 1998. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes, 47, 1920-1927.
42. Banarer, S., Cryer, P.E. 2003. Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes, 52, 1195-1203.
43. Gale, E., Tattersall, R. 1979. Unrecognized nocturnal hypoglycaemia in insulin treated diabetics. Lancet, 1, 1049-1052.
44. Bendtson, I., Kverneland, A., Pramming, S., Binder, C. 1988. Incidence of nocturnal hypoglycaemia in insulin-dependent diabetic patients on intensive therapy. Acta Medica Scandinavica, 223, 543-548.
45. Whincup, G., Milner, R.D. 1987. Prediction and management of nocturnal hypoglycemia in diabetes. Archives of Disease in Childhood, 62, 333-337.
46. Shalwitz, R.A., Farkas-Hirsch, R., White, N.H., Santiago, J.V. 1990. Prevalence and consequences of nocturnal hypoglycemia in conventionally treated children with diabetes mellitus. Journal of Pediatrics, 116, 685-689.
47. Matyka, K.A., Crawford, C., Wiggs, L., Dunger, D., Stores, G. 2000. Alterations in sleep physiology in young children with insulin dependent diabetes mellitus: relationship to nocturnal hypoglycaemia. Journal of Pediatrics, 137, 233-238.
48. Porter, P., Keating, B., Byrne, G.C., Jones, T.W. 1997. Incidence and predictive criteria of nocturnal hypoglycaemia in young children with insulin dependent diabetes mellitus. Journal of Pediatrics, 130, 366-372.
49. Wentholt, I.M., Maran, A., Masurel, N., Heine, R.J., Hoekstra, J.B., DeVries, J.H. 2007. Nocturnal hypoglycaemia in type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. Diabetic Medicine, 24, 527-532.
50. Vervoort, G., Goldschmidt, H.M., van Doorn, L.G. 1996. Nocturnal blood glucose profi les in patients with type 1 diabetes mellitus on multiple > or = 4) daily insulin injection regimens. Diabetic Medicine, 13, 794-799.
51. Jones, T.W., Davis, E.A. 2003. Hypoglycemia in children with type 1 diabetes: current issues and controversies. Pediatric Diabetes, 4, 143-150.
52. Davis, E.A., Keating, B., Byrne, G.C., Russell, M., Jones, T.W. 1998. The impact of improved glycaemic control on rates of hypoglycaemia in patients with IDDM. Archives of Disease in Childhood, 78, 111-115.
53. Danne, T., Mortensen, H.B., Hougaard, P., Lynggaard, H., Aanstoot, H.J., Chiarelli, F., Daneman, D., Dorchy, H., Garandeau, P., Greene, S.A., Hoey, H., et al. 2001. For the Hvidøre Study Group on Childhood Diabetes: persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care, 24, 1342-1347.
54. Nordfelt, S., Ludvigsson, J. 1999. Adverse events in intensively treated children and adolescents with type 1 diabetes. Acta Paediatrica Scandinavica, 88, 1184-1193.
55. Rewers, A., Chase, H.P., Mackenzie, T., Walravens, P., Roback, M., Rewers, M., Hamman, R.F., Klingensmith, G. 2002. Predictors of acute complications in children with type 1 diabetes. Journal of the American Medical Association, 287, 2511-2518.
56. Davis, E.A., Keating, B., Byrne, G.C., Russell, M., Jones, T.W. 1997. Hypoglycaemia: incidence and clinical predictors in a large population based sample of children and adolescents with IDDM. Diabetes Care, 20, 22-25.
57. Northam, E., Anderson, P., Jacobs, P., Hughes, M., Warne, G., Werther, G.A. 2001. Neuropsychological profi les of children with diabetes 6 years after disease onset. Diabetes Care, 24, 1541-1546.
58. Scoenle, E.J., Schoenle, D., Molinari, L., Largo, R.H. 2002. Impaired intellectual development in children with type 1 diabetes: association with HbA1c, age at diagnosis and sex. Diabetologia, 45, 108-114.
59. Rovet, J.F., Ehrlich, R.M., Hoppe, M. 1988. Specifi c intellectual defi cits in children with early onset diabetes mellitus. Child Development, 59, 226-234.
60. Rovet, J. 1999. Neuropsychological sequelae of paediatric diabetes. In: Yeates, K., Ris, M., Taylor, H. (Eds.), Paediatric Neuropsychologic Research, Theory and Practice, Guilford Press, New York, pp. 336-365.
61. Ryan, C., Vega, A., Drash, A. 1985. Cognitive defi cits in adolescents who developed diabetes early in life. Pediatrics, 75, 921-927.
62. Cox, D., Clarke, W., Gonder-Frederick, L., Kovatchev, B. 2001. Driving mishaps and hypoglycaemia: risk and prevention. International Journal of Clinical Practice Supplement, 123, 38-42.
63. Ryan, C.M., Geckle, M.O., Orchard, T.J. 2003. Cognitive effi ciency declines over time in adults with type 1 diabetes: effects of micro-and macrovascular complications . Diabetologia, 46, 940-948.
64. Brands, A.M., Biessels, G.J, de Haan, E.H., Kappelle, L.J., Kessels, R.P. 2005. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care, 28, 726-735.
65. Thorsell, A., Gordon, M., Jovanovic, L. 2004. Continuous glucose monitoring: a stepping stone in the journey towards a cure for diabetes. Journal of Maternal - Fetal & Neonatal Medicine, 15, 15-25.
66. Williams, A.F. 1997. Hypoglycaemia of the newborn: a review. Bulletin of the World Health Organization, 75, 261-290.
67. Kovatchev, B.P., Cox, D.J., Kumar, A., Gonder-Frederick, L., Clarke, W.L. 2003. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technology & Therapeutics, 5, 817-828.
68. Ho, K.L., Loke, H.L, Tan, K.W. 1991. Accuracy and reliability of two methods of screening for hypoglycemia in neonates. Journal of the Singapore Paediatric Society, 33, 156-158.
69. Hall, D.M.B., Michael, J.M. 1995. Screening in infancy. Archives of Disease in Childhood, 72, 93-96.
70. Ellis, M., Manandhar, D.S., Manandhar, N., Land, J.M., Patel, N., del Costello, A.M. 1996. Comparison of two cotside methods for the detection of hypoglycaemia among neonates in Nepal. Archives of Disease in Childhood Fetal Neonatal, 75, F122-F125.
71. Dahlberg, M., Whitelaw, A. 1997. Evaluation of HemoCue Blood Glucose Analyzer for the instant diagnosis of hypoglycaemia in newborns. Scandinavian Journal of Clinical and Laboratory Investigation, 57, 719-724.
72. Leonard, M., Chessall, M., Manning, D. 1997. The use of a Hemocue blood glucose analyser in a neonatal unit. Annals of Clinical Biochemistry, 34,287-290.
73. Buckingham, B., Caswell, K., Wilson, D.M. 2007. Real-time continuous glucose monitoring. Current Opinion in Endocrinology, Diabetes, and Obesity, 14,288-295.
74. Heise, T., Koschinsky, T., Heinemann, L., Lodwig, V. 2003. Glucose Monitoring Study Group: Hypoglycemia warning signal and glucose sensors: requirements and concepts. Diabetes Technology & Therapeutics, 5, 563-571.
75. Bode, B.W., Sabbah, H., Davidson, P.C. 2001. What's ahead in glucose monitoring? New techniques hold promise for improved ease and accuracy. Postgraduate Medicine, 109, 41-44, 47-49.
76. Moberg, E., Hagström-Toft, E., Arner, P., Bolinder, J. 1997. Protracted glucose fall in subcutaneous adipose tissue and skeletal muscle compared with blood during insulin-induced hypoglycaemia. Diabetologia, 40, 1320-1326.
77. Aussedat, B., Dupire-Angel, M., Gifford, R., Klein, J.C., Wilson, G.S., Reach, G. 2000. Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. American Journal of Physiology: Endocrinology and Metabolism, 278, E716-E728.
78. Melki, V., Ayon, F., Fernandez, M., Hanaire-Broutin, H. 2006. Value and limitations of the Continuous Glucose Monitoring System in the management of type diabetes. Diabetes & Metabolism, 32, 123-129.
79. Wentholt, I.M., Hart, A.A., Hoekstra, J.B., Devries, J.H. 2007. Relationship between interstitial and blood glucose in type 1 diabetes patients: delay and the push-pull phenomenon revisited. Diabetes Technology & Therapeutics, 9,169-175.
80. McGowan, K., Thomas, W., Moran, A. 2002. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care, 25, 1499-1503. Erratum in: Diabetes Care, 2003, 26, 553.
81. Diabetes Research in Children Network (Direcnet) Study Group, Buckingham, B.A., Kollman, C., Beck, R., Kalajian, A., Fiallo-Scharer, R., Tansey, M.J., Fox, L.A., Wilson, D.M., Weinzimer, S.A., Ruedy, K.J., Tamborlane, W.V. 2006. Evaluation of factors affecting CGMS calibration. Diabetes Technology & Therapeutics, 8, 318-325.
82. Moatti-Sirat, D., Capron, F., Poitout, V., Reach, G., Bindra, D.S., Zhang, Y., Wilson, G.S., Thévenot, D.R. 1992. Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue. Diabetologia, 35, 224-230.
83. Rebrin, K., Fischer, U., Hahn von Dorsche, H., von Woetke, T., Abel, P., Brunstein, E. 1992. Subcutaneous glucose monitoring by means of electrochemical sensors: fi ction or reality? Journal of Biomedical Engineering, 14, 33-40.
84. Reach, G. 2008. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technology & Therapeutics, 10, 69-80.
85. Reach, G. 2001. Which threshold to detect hypoglycemia? Value of receiver - operator curve analysis to fi nd a compromise between sensitivity and specifi city. Diabetes Care, 24, 803-804.
86. Shichiri, M., Kawamori, R., Yamasaki, Y., Hakui, N., Abe, H. 1982. Wearable artifi cial endocrine pancrease with needle-type glucose sensor. Lancet, 2, 1129-1131.
87. Mastrototaro, J. 1999. The MiniMed Continuous Glucose Monitoring System (CGMS). Journal of Pediatric Endocrinology & Metabolism, 12 3, 751-758.
88. Yogev, Y., Chen, R., Ben-Haroush, A., Phillip, M., Jovanovic, L., Hod, M. 2003. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstetrics and Gynecology, 101, 633-638.
89. Metzger, M., Leibowitz, G., Wainstein, J., Glaser, B., Raz, I. 2002. Reproducibility of glucose measurements using the glucose sensor. Diabetes Care, 25, 1185-1191.
90. Jovanovic, L. 2000. The role of continuous glucose monitoring in gestational diabetes mellitus. Diabetes Technology & Therapeutics, 2, 67-71.
91. Rao, G., Glikfeld, P., Guy, R.H. 1993. Reverse iontophoresis: development of a noninvasive approach for glucose monitoring. Pharmaceutical Research, 10, 1751-1755.
92. Jovanovic, L., Yogev, Y., Hod, M. 2003. Optimal monitoring of glycemia and defi nitions of normoglycemia. In: Dunitz, M. (Ed.), Textbook of Diabetes and Pregnancy, Taylor & Francis, London, pp. 345-376.
93. Tavris, D.R., Shoaibi, A. 2004. The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS): an assessment of the literature . Diabetes Technology & Therapeutics, 6, 518-522.
94. Chico, A., Vidal-Ríos, P., Subirà, M., Novials, A. 2003. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care, 26, 1153-1157.
95. Korf, J., Tiessen, R.G., Venema, K., Rhemrev, M.M. 2003. Biosensors for continuous glucose and lactate monitoring. Nederlands Tijdschrift voor Geneeskunde, 1204-1208.
96. Kubiak, T., Hermanns, N., Schreckling, H.J., Kulzer, B., Haak, T. 2004. Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabetic Medicine, 21, 487-490.
97. Gross, T.M., Mastrototaro, J.J. 2000. Effi cacy and reliability of the continuous glucose monitoring system. Diabetes Technology & Therapeutics, 2 1, S19-S26.
98. Beardsall, K., Ogilvy-Stuart, A.L., Ahluwalia, J., Thompson, M., Dunger, D.B. 2005. The continuous glucose monitoring sensor in neonatal intensive care. Archives of Disease in Childhood Fetal Neonatal, 90, F307-F310.
99. Sternberg, F., Meyerhoff, C., Mennel, F.J., Mayer, H., Bischof, F., Pfeiffer, E.F. 1996. Does fall in tissue glucose precede fall in blood glucose? Diabetologia, 609-612.
100. Keck, F.S., Kerner, W., Meyerhoff, C., Zier, H., Pfeiffer, E.F. 1991. Combination of microdialysis and GlucoSensor permits continuous (on line) s.c. glucose monitoring in a patient operated device: I. In vitro evaluation. Hormone and Metabolic Research, 23, 617-618.
101. Hashiguchi, Y., Sakakida, M., Nishida, K., Uemura, T., Kajiwara, K., Shichiri, M. 1994. Development of a miniaturized glucose monitoring system by combining a needle-type glucose sensor with microdialysis sampling method: long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patients. Diabetes Care, 17, 387-396.
102. Meyerhoff, C., Mennel, F.J., Bischof, F., Sternberg, F., Pfeiffer, E.F. 1994. Combination of microdialysis and glucose sensor for continuous on line measurement of the subcutaneous glucose concentration: theory and practical application . Hormone and Metabolic Research, 26, 538-543.
103. Bolinder, J., Hagström-Toft, E., Ungerstedt, U., Arner, P. 1997. Self-monitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care, 20, 64-70.
104. Fayolle, C., Brun, J.F., Bringer, J., Mercier, J., Renard, E. 2006. Accuracy of continuous subcutaneous glucose monitoring with the GlucoDay in type 1 diabetic patients treated by subcutaneous insulin infusion during exercise of low versus high intensity. Diabetes & Metabolism, 32, 313-320.
105. Maran, A., Crepaldi, C., Tiengo, A., Grassi, G., Vitali, E., Pagano Gbistoni, S., Calabrese, G., Santeusanio, F., Leonetti, F., Ribaudo, M., et al. 2002. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care, 25, 347-352.
106. Wentholt, I.M., Vollebregt, M.A., Hart, A.A., Hoekstra, J.B., DeVries, J.H. 2005. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. Diabetes Care, 28, 2871-2876.
107. Esmatjes, E., Flores, L., Vidal, M., Rodriguez, L., Cortés, A., Almirall, L., Ricart, M.J., Gomis, R. 2003. Hypoglycaemia after pancreas transplantation: usefulness of a continuous glucose monitoring system. Clinical Transplantation, 17,-538.
108. Sparacino, G., Zanderigo, F., Corazza, S., Maran, A., Facchinetti, A., Cobelli, C. 2007. Glucose concentration can be predicted ahead in time from continuous glucose monitoring sensor time-series. IEEE Transactions on Bio-medical Engineering, 54, 931-937.
109. Hermanides, J., Wentholt, I.M., Hart, A.A., Hoekstra, J.B., DeVries, J.H. 2008. No apparent local effect of insulin on microdialysis continuous glucose-monitoring measurements. Diabetes Care, 31, 1120-1122.
110. Bolinder, J., Ungerstedt, U., Arner, P. 1993. Long term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet, 342, 1080-1085.
111. Hagström-Toft, E., Hellström, L., Moberg, E. 1998. Lipolytic response during spontaneous hypoglycaemia in insulin-dependent diabetic subjects. Hormone and Metabolic Research, 30, 586-593.
112. Hildingsson, U., Sellden, H., Ungerstedt, U., Marcus, C. 1996. Microdialysis for metabolic monitoring in neonates after surgery. Acta Paediatrica Scandinavica, 589-594.
113. Anand, K.J.S., Brown, M.J., Causon, R.C., Christofi des, N.D., Bloom, S.R., Aynsley-Green, A. 1985. Can the human neonate mount an endocrine and metabolic response to surgery? Journal of Pediatric Surgery, 20, 41-48.
114. Anand, K.J.S., Sippel, W.G., Aynsley-Green, A. 1987. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet, 1, 243-248.
115. Ward Platt, M.P., Tarbit, M.J., Aynsley-Green, A. 1990. The effects of anesthesia and surgery on metabolic homeostasis in infancy and childhood. Journal of Pediatric Surgery, 25, 472-478.
116. Vlasselaers, D., Schaupp, L., van den Heuvel, I., Mader, J., Bodenlenz, M., Suppan, M., Wouters, P., Ellmerer, M., van den Berghe, G. 2007. Monitoring blood glucose with microdialysis of interstitial fl uid in critically ill children. Clinical Chemistry, 53, 536-537.
117. Ellmerer, M., Haluzik, M., Blaha, J., Kremen, J., Svacina, S., Toller, W., Mader, J., Schaupp, L., Plank, J., Pieber, T. 2006. Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery. Diabetes Care, 29, 1275-1281.
118. De Backer, D., Creteur, J., Preiser, J.C., Dubois, M.J., Vincent, J.L. 2002. Microvascular blood fl ow is altered in patients with sepsis. American Journal of Respiratory and Critical Care Medicine, 166, 98-104.
119. Sair, M., Etherington, P.J., Peter Winlove, C., Evans, T.W. 2001. Tissue oxygenation and perfusion in patients with systemic sepsis. Critical Care Medicine, 29, 1343-1349.
120. Kamel, A., Norgren, S., Persson, B., Marcus, C. 1999. Insulin induced hypoglycaemia: comparison of glucose and glycerol concentrations in plasma and microdialysate from subcutaneous adipose tissue. Archives of Disease in Childhood, 42-45.
121. Moberg, E., Hagström-Toft, E., Bolinder, J. 1997. Detection of hypoglycaemia by microdialysis measurements of glucose in subcutaneous adipose tissue. Hormone and Metabolic Research, 29, 440-443.
122. Rajamand, N., Ungerstedt, U., Brismar, K. 2005. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus. Diabetes, Obesity & Metabolism, 7, 525-535.
123. Baumeister, F.A., Hack, A., Busch, R. 2006. Glucose-monitoring with continuous subcutaneous microdialysis in neonatal diabetes mellitus. Klinische Padiatrie, 230-232.
124. Baumeister, F.A., Rolinski, B., Busch, R., Emmrich, P. 2001. Glucose monitoring with long-term subcutaneous microdialysis in neonates. Pediatrics, 108, 1187-1192.
125. Holzinger, A., Bonfi g, W., Kusser, B., Eggermann, T., Muller, H., Munch, H.G. 2006. Use of long-term microdialysis for subcutaneous glucose monitoring in the management of neonatal diabetes: a fi rst case report. Biology of the Neonate, 88-91.
126. Bailey, T.S., Zisser, H.C., Garg, S.K. 2007. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technology & Therapeutics, 9, 203-210.
127. Bugler, J.R., Bergenstal, R.M., Bode, B.W., Weinstein, R.L., Schwartz, S.L., Bernstein, R.M., El-Deiry, S.S. 2006. Home use evaluation of the Free-Style Navigator continuous glucose monitoring system. Diabetologia, 49 (Suppl), 0957.
128. Deiss, D., Bolinder, J., Riveline, J.P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., Phillip, M. 2006. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care, 29, 2730-2732.
129. Garg, S., Jovanovic, L. 2006. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profi les obtained using a 7-day continuous glucose sensor. Diabetes Care, 29, 2644-2649.
130. Garg, S.K., Schwartz, S., Edelman, S.V. 2004. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care, 27, 734-738.
131. Garg, S.K., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., Jovanovic, L. 2006. Improvement in glycemic excursion with a transcutaneous, real-time continuous glucose sensor: a randomized control trial. Diabetes Care, 29, 44-50.
132. Clough, G., Noble, M. 2003. Microdialysis: a model for studying chronic wounds. International Journal of Lower Extremity Wounds, 2 4, 233-239.
133. Harding, K.G., Morris, H.L., Patel, G.K. 2002. Science, medicine and the future: healing chronic wounds. British Medical Journal, 324 7330, 160-163.
134. Simonsen, L., Holstein, P., Larsen, K., Bülow, J. 1998. Glucose metabolism in chronic diabetic foot ulcers measured in vivo using microdialysis. Clinical Physiology, 18 4, 355-359.
135. Stolle, L.B., Riegels-Nielsen, P. 2004. Acta Orthopaedica Scandinavica, 75 1,106-108.
136. Latijnhouwers, M.A., Bergers, M., Veenhuis, R.T., Beekman, B., Ankersmit-Ter Horst, M.F., Schalkwijk, J. 1998. Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity. Archives of Dermatological Research,9, 490-496.
137. Weckroth, M., Vaheri, A., Myohanen, H., Tukiainen, E., Siren, V. 2001. Differential effects of acute and chronic wound fl uids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fi broblasts. Wound Repair and Regeneration, 9 4, 314-322.
138. Weckroth, M., Vaheri, A., Lauharanta, J., Sorsa, T., Konttinen, Y.T. 1996. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. Journal of Investigative Dermatology, 106 5, 1119-1124.
139. Hoffman, R., Starkey, S., Coad, J. 1998. Wound fl uid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes. Journal of Investigative Dermatology, 111 6, 1140-1144.
140. Fivenson, D.P., Faria, D.T., Nickoloff, B.J., Poverini, P.J., Kunkel, S., Burdick, M., Strieter, R.M. 1998. Chemokine and infl ammatory cytokine changes during chronic wound healing. Wound Repair and Regeneration, 5 4, 310-322.
141. Petersen, L.J., Church, M.K., Skov, P.S. 1997. Histamine is released in the wheal but not the fl are following challenge of human skin in vivo: a microdialysis study. Clinical and Experimental Allergy, 27 3, 284-595.
142. Clough, G.F. 1999. Role of nitric oxide in the regulation of microvascular perfusion in human skin in vivo. Journal of Physiology, 516 2, 549-557.
143. Church, M.K., Griffiths, T.J., Jeffery, S., Ravell, L.C., Cowburn, A.S., Sampson, A.P., Clough, G.F. 2002. Are cysteinyl leukotrienes involved in allergic responses in human skin? Clinical and Experimental Allergy, 32 7, 1013-1019.
144. Caldwell, M.D. 1988. Carbohydrate and energy metabolism in healing wounds. Progress in Clinical and Biological Research, 266, 183-213.
145. Daley, J.M., Shearer, J.D., Mastrofrancesco, B., Caldwell, M.D. 1990. Glucose metabolism in injured tissue: a longitudinal study. Surgery, 107 2, 187-192.
146. Wilmore, D.W., Aulick, L.H. 1978. Metabolic changes in burned patients. Surgical Clinics of North America, 58 6, 1173-1187.
147. Simonsen, L., Bülow, J., Madsen J. 1994. Adipose tissue metabolism in humans determined by vein catherization and microdialysis technique. American Journal of Physiology, 266 3 Pt. 1, E357-E365.
148. Rhodes, L.E., Belgi, G., Parslew, R., McLoughlin, L., Clough, G.F., Friedmann, P.S. 2001. Ultraviolet-B-induced erythema is mediated by nitric oxide and prostaglandin E2 in combination. Journal of Investigative Dermatology, 117 4,880-885.
149. Krogstad, A.L., Lönnroth, P., Larson, G., Wallin, B.G. 1997. Increased interstitial histamine concentration in the psoriatic plaque. Journal of Investigative Dermatology, 109 5, 632-635.
150. Peterson, L.R., Lissack, L.M., Canter, K., Fasching, C.E., Clabots, C., Gerding, D.N. 1989. Therapy of lower extremity infections with ciprofl oxacin in patients with diabetes mellitus, peripheral vascular disease, both. American Journal of Medicine, 86 6 Pt. 2, 801-808.
151. Lassen, N.A. 1973. General discussion on occlusive arterial disease in diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation Supplement, 1128, 235-237.
152. Legat, F.J., Maier, A., Dittrich, P., Zenahlik, P., Kern, T., Nuhsbaumer, S., Frossard, M., Salmhofer, W., Kerl, H., Müller, M. 2003. Penetration of fosfomycin into infl ammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrobial Agents and Chemotherapy, 47 1, 371-374.
153. Legat, F.J., Krause, R., Zenahlik, P., Hoffmann, C., Scholz, S., Salmhofer, W., Tscherpel, J., Tscherpel, T., Kerl, H., Dittrich, P. 2005. Penetration of piperacillin and tazobactam into infl amed soft tissue of patients with diabetic foot infection. Antimicrobial Agents and Chemotherapy, 49 10, 4368-4371.
154. Müller, M., Brunner, M., Hollenstein, U., Joukhadar, C., Schmid, R., Minar, E., Ehringer, H., Eichler, H.G. 1999. Penetration of ciprofl oxacin into the interstitial space of infl amed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrobial Agents and Chemotherapy, 43 8, 2056-2058.
155. Bellmann, R., Kuchling, G., Dehghanyar, P., Zeitlinger, M., Minar, E., Mayer, B.X., Müller, M., Joukhadar, C. 2004. Tissue pharmacokinetics of levofl oxacin in human soft tissue infections. British Journal of Clinical Pharmacology, 57 5,563-568.
156. Burgmann, H., Georgopoulos, A., Graninger, W., Koppensteiner, R., Maca, T., Minar, E., Schneider, B., Stümpfl en, A., Ehringer, H. 1996. Tissue concentration of clindamycin and gentamicin near ischaemic ulcers with transvenous injection in Bier's arterial arrest. Lancet, 348 9030, 781-783.
157. Dan, M., Torossian, K., Weissberg, D., Kitzes, R. 1993. The penetration of ciprofl oxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration. European Journal of Clinical Pharmacology, 44 1,101-102.
158. Fong, I.W., Ledbetter, W.H., Vandenbroucke, A.C., Simbul, M., Rahm, V. 1986. Ciprofl oxacin concentrations in bone and muscle after oral dosing. Antimicrobial Agents and Chemotherapy, 29 3, 405-408.
159. Müller, M., Brunner, M., Schmid, R., Putz, E.M., Schmiedberger, A., Wallner, I., Eichler, H.G. 1998. Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans. Life Sciences, 62 15, PL227-PL234.
160. Wise, R., Donovan, I.A. 1987. Tissue penetration and metabolism of ciprofl oxacin . American Journal of Medicine, 82 4A, 103-107.
161. Brunner, M., Hollenstein, U., Delacher, S., Jäger, D., Schmid, R., Lackner, E., Georgopoulos, A., Eichler, H.G., Müller, M. 1999. Distribution and antimicrobial activity of ciprofl oxacin in human soft tissues. Antimicrobial Agents and Chemotherapy, 43 5, 1307-1309.
162. Müller, M., Haag, O., Burgdorff, T., Georgopoulos, A., Weninger, W., Jansen, B., Stanek, G., Pehamberger, H., Agneter, E., Eichler, H.G. 1996. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrobial Agents and Chemotherapy, 40 12, 2703-2709.
163. Ryan, D.M., Cars, O., Hoffstedt, B. 1986. The use of antibiotic serum levels to predict concentrations in tissues. Scandinavian Journal of Infectious Diseases,5, 381-388.
164. Seabrook, G.R., Edmiston, C.E., Schmitt, D.D., Krepel, C., Bandyk, D.F., Towne, J.B. 1991. Comparison of serum and tissue antibiotic levels in diabetes-related foot infections. Surgery, 110 4, 671-676.
165. Joukhadar, C., Derendorf, H., Müller, M. 2001. Microdialysis. A novel tool for clinical studies of anti-infective agents. European Journal of Clinical Pharmacology,3, 211-219.
166. Bergogne-Bérézin, E. 2002. Clinical role of protein binding of quinolones. Clinical Pharmacokinetics, 41 10, 741-750.
167. Maeda, H., Akaike, T., Wu, J., Noguchi, Y., Sakata, Y. 1996. Bradykinin and nitric oxide in infectious disease and cancer. Immunopharmacology, 33 1-3,222-230.
168. Chantelau, E. 1999. Pathogenesis of diabetic foot disease. Internist Berlis,10, 994-1001 (in German).
169. Joukhadar, C., Klein, N., Frossard, M., Minar, E., Stass, H., Lackner, E., Herrmann, M., Riedmüller, E., Müller, M. 2001. Angioplasty increases target site concentrations of ciprofl oxacin in patients with peripheral arterial occlusive disease. Clinical Pharmacology & Therapeutics, 70 6, 532-539.
170. Joukhadar, C., Stass, H., Müller-Zellenberg, U., Lackner, E., Kovar, F., Minar, E., Müller, M. 2003. Penetration of moxifl oxacin into healthy and infl amed subcutaneous adipose tissues in humans. Antimicrobial Agents and Chemotherapy,10, 3099-3103.
171. Capecchi, P.L., Blardi, P., De Lalla, A., Ceccatelli, L., Volpi, L., Pasini, L., Di Perri, T. 1995. Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofl oxacin in humans. Clinical Pharmacology & Therapeutics, 57 4, 446-454.
172. Licitra, C.M., Brooks, R.G., Sieger, B.E. 1987. Clinical effi cacy and levels of ciprofl oxacin in tissue in patients with soft tissue infection. Antimicrobial Agents and Chemotherapy, 31 5, 805-807.
173. Müller, M., Schmid, R., Georgopoulos, A., Buxbaum, A., Wasicek, C., Eichler, H.G. 1995. Application of microdialysis to clinical pharmacokinetics in humans. Clinical Pharmacology & Therapeutics, 57 4, 371-380.
174. Frossard, M., Joukhadar, C., Erovic, B.M., Dittrich, P., Mrass, P.E., Van Houte, M., Burgmann, H., Georgopoulos, A., Müller, M. 2000. Distribution and antimicrobial activity of fosfomycin in the interstitial fl uid of human soft tissues. Antimicrobial Agents and Chemotherapy, 44 10, 2728-2732.
175. Dalla Costa, T., Nolting, A., Kovar, A., Derendorf, H. 1998. Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis. Journal of Antimicrobial Chemotherapy, 42 6, 769-778.
176. Perry, C.M., Markham, A. 1999. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs, 57 5, 805-843.
177. Kim, S.H, Abbasi, F., Reaven, G.M. 2004. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care, 27, 1998-2002.
178. Despres, J.P., Lamarche, B., Mauriege, P., Cantin, B., Dagenais, G.R., Moorjani, S., Lupien, P.J. 1996. Hyperinsulinemia as an independent risk factor for ischemic heart disease. New England Journal of Medicine, 334 15, 952-957.
179. Shanik, M.H., Xu, Y., Skrha, J., Dankner, R., Zick, Y., Roth, J. 2008. Insulin resistance and hyperinsulinemia: Is hyperinsulinemia the cart or the horse? Diabetes Care, 31 2, S262-S268.
180. Rizza, R.A., Mandarino, L.J., Genest, J., Baker, B.A., Gerich, J.E. 1985. Production of insulin resistance by hyperinsulinemia in man. Diabetologia, 28,-75.
181. Groop, L.C., Bonadonna, R.C., Shank, M., Petrides, A.S., DeFronzo, R.A. 1991. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. Journal of Clinical Investigation, 87, 83-89.
182. Abdul-Ghani, M.A., Matsuda, M., Balas, B., DeFronzo, R.A. 2007. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care, 30, 89-94.
183. DeFronzo, R.A. 1988. Lilly Lecture: The triumvariate: β-cell, muscle, liver, a collusion responsible for NIDDM. Diabetes, 37, 667-687.
184. Frossard, M., Blank, D., Joukhadar, Ch., Bayegan, K., Schmid, R., Luger, A., Müller, M. 2005. Interstitial glucose in skeletal muscle of diabetic patients during an oral glucose tolerance test. Diabetic Medicine, 22 1, 56-60.
185. Cline, G.W., Petersem, K.F., Kossak, M., Shen, J., Hundal, R.S., Trajanoski, Z., Inzucchi, S., Dreszer, A., Rothman, D.L., Hulman, G.I. 1999. Impaired glucose transport as a cause of decreased insulin stimulated muscle glycogen synthesis in type 2 diabetes. New England Journal of Medicine, 341, 240-246.
186. Niklasson, M., Holmäng, A., Sjöstrand, M., Strindberg, L., Lönnroth, P. 2000. Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects. Diabetes, 49, 1178-1185.